Dr. Anitha Singareddy MD

Dr. Anitha Singareddy is a board-certified physician and Head of Medical & Scientific Affairs at Image Analysis Group (IAG), where she leads imaging strategy and clinical research for oncology and immuno-oncology trials. With 17 years of experience across clinical practice and clinical research, she brings expertise in clinical trial design, imaging endpoints, and the execution of imaging-intensive studies.

Dr. Singareddy’s career has been built at the intersection of clinical medicine and research. Her medical training provided a strong foundation in patient care before she transitioned into clinical research, where she developed deep expertise in imaging methodologies and review criteria that underpin modern drug development across solid and hematologic malignancies. With over 17 years of combined clinical and clinical research experience, she has worked across Phase I–III programs, collaborating with globally distributed radiology readers and multidisciplinary teams to support the development and regulatory approval of advanced therapies.

Dr. Singareddy has extensive expertise in oncology imaging review criteria, including RECIST 1.1, iRECIST, mRECIST, and Lugano, which guide tumor response assessment and evaluation in clinical trials. She has led imaging programs across solid and hematologic malignancies and coordinated global reader panels for Phase I–III studies. Her work has supported the clinical development and regulatory approval of advanced therapies across oncology and immuno-oncology..

At IAG, Dr. Singareddy manages the oncology and immuno-oncology program portfolio, overseeing the scientific and operational execution of imaging trials from protocol design through data delivery. She works closely with IAG’s radiology reader network and technology teams to ensure imaging endpoints are applied consistently and that the resulting data meets the standards required for clinical development and regulatory use.